Clin2
NCT07229534Possibly a fitNot yet recruiting

Study of a new diabetes medicine for type 2 diabetes

Diabete Mellitus

Part of Hormones & metabolism clinical trials.

This study tests a new diabetes medication (DA-5218) added to your current metformin treatment to see if it improves blood sugar control safely. It may help you manage your type 2 diabetes better.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
238 people
Ages
19 years and older
Study type
Interventional

Who can take part

  • You have type 2 diabetes
  • Your A1C (average blood sugar) is between 7% and 10.5%
  • Your fasting blood sugar is 270 mg/dL or lower
  • You have been taking metformin 1,000 mg per day for at least 8 weeks
  • You do not have severe kidney or liver problems

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07239440Not yet recruiting· Phase 2
Adding DA-2811 to standard diabetes treatment

This study tests whether adding a new medicine called DA-2811 to your current diabetes medicines helps lower blood sugar more effectively in people with type 2 diabetes.

Seoul
NCT07794254Not yet recruiting· Phase 1
Experimental medicine for insulin-treated type 2 diabetes

This study tests an experimental medicine called RGB-5088 for people with type 2 diabetes who are already using insulin. The goal is to see if it can safely improve blood sugar control when added to your current diabetes management.

Beijing, Beijing Municipality
NCT07755150Not yet recruiting· Phase 2
Study of an experimental pill for type 2 diabetes

This trial tests an experimental pill called DA-302168S to see if it helps lower blood sugar in people with type 2 diabetes. It is for patients who are already managing their diabetes with metformin or lifestyle changes, and it focuses on safety and effectiveness over about 6 months.

Beijing
NCT07379333Recruiting· Phase 3
Testing a new drug for type 2 diabetes when metformin and dapagliflozin aren't enough

This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.

Gyeonggi-do
NCT07394114Recruiting· Phase 3
Study of a new medicine for type 2 diabetes not controlled by diet and exercise

This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.

Beijing
NCT07527650Recruiting· Phase 2
Testing HM15275 for Type 2 Diabetes Management

This study tests a new medication called HM15275 to help control blood sugar in people with type 2 diabetes. The trial will check if the medication works well and is safe when added to diet, exercise, or metformin treatment.

Mesa, Arizona

Hear when a new Diabete Mellitus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.